These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 16620837
1. Relation between charge-based apolipoprotein B-containing lipoprotein subfractions and remnant-like particle cholesterol levels. Zhang B, Böttcher A, Imaizumi S, Noda K, Schmitz G, Saku K. Atherosclerosis; 2007 Mar; 191(1):153-61. PubMed ID: 16620837 [Abstract] [Full Text] [Related]
3. Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis. Zhang B, Katafuchi R, Arishima H, Matsunaga A, Rye KA, Saku K. Clin Chim Acta; 2006 Nov; 373(1-2):55-61. PubMed ID: 16806136 [Abstract] [Full Text] [Related]
4. Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study. Zhang B, Matsunaga A, Rainwater DL, Miura S, Noda K, Nishikawa H, Uehara Y, Shirai K, Ogawa M, Saku K. J Lipid Res; 2009 Sep; 50(9):1832-41. PubMed ID: 19056704 [Abstract] [Full Text] [Related]
8. Reduction of charge-modified LDL by statin therapy in patients with CHD or CHD risk factors and elevated LDL-C levels: the SPECIAL Study. Zhang B, Miura S, Yanagi D, Noda K, Nishikawa H, Matsunaga A, Shirai K, Iwata A, Yoshinaga K, Adachi H, Imaizumi T, Saku K. Atherosclerosis; 2008 Dec; 201(2):353-9. PubMed ID: 18395728 [Abstract] [Full Text] [Related]
11. Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets. Kappelle PJ, Dallinga-Thie GM, Dullaart RP, Diabetes Atorvastatin Lipid Intervention (DALI) study group. Biochim Biophys Acta; 2010 Jan; 1801(1):89-94. PubMed ID: 19800983 [Abstract] [Full Text] [Related]
12. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size. Tani S, Matsumoto M, Nagao K, Hirayama A. J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623 [Abstract] [Full Text] [Related]
13. Serum remnant lipoprotein cholesterol/triglyceride ratio as an index for screening familial type III hyperlipidaemia. Nakajima K, Daimon M, Kamiyama K, Takanashi K, Suzuki Y, Watanabe M, Kubono K, Saniabadi AR, Takashima S, Sakurabayashi I. Ann Clin Biochem; 2007 Jul; 44(Pt 4):353-9. PubMed ID: 17663088 [Abstract] [Full Text] [Related]
14. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques. Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T. Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082 [Abstract] [Full Text] [Related]
18. Changes in lipid metabolism in postmenopausal Japanese women using hormone therapy evaluated by capillary isotachophoresis: a pilot study. Inoue Y, Zhang B, Sadamori R, Shirota K, Saku K, Kawarabayashi T. Menopause; 2008 Nov; 15(1):157-63. PubMed ID: 17603392 [Abstract] [Full Text] [Related]
19. Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state. Marcoux C, Hopkins PN, Wang T, Leary ET, Nakajima K, Davignon J, Cohn JS. J Lipid Res; 2000 Sep; 41(9):1428-36. PubMed ID: 10974050 [Abstract] [Full Text] [Related]
20. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome. Chan DC, Watts GF, Ng TW, Yamashita S, Barrett PH. Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799 [Abstract] [Full Text] [Related] Page: [Next] [New Search]